• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bin1通过c-Myc在转化的原代细胞中介导细胞凋亡。

Bin1 mediates apoptosis by c-Myc in transformed primary cells.

作者信息

DuHadaway J B, Sakamuro D, Ewert D L, Prendergast G C

机构信息

The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.

出版信息

Cancer Res. 2001 Apr 1;61(7):3151-6.

PMID:11306501
Abstract

The Bin1 gene encodes a c-Myc-interacting adapter protein with tumor suppressor and cell death properties. In this study, we offer evidence that Bin1 participates in a mechanism through which c-Myc activates programmed cell death in transformed primary chick or rat cells. Antisense or dominant inhibitory Bin1 genes did not affect the ability of c-Myc to drive proliferation or transformation, but they did reduce the susceptibility of cells to c-Myc-induced apoptosis. Protein-protein interaction was implicated, suggesting that Bin1 mediates a death or death sensitization signal from c-Myc. Our findings offer direct support for the "dual signal" model of Myc apoptotic function, based on interactions with a binding protein. Loss of Bin1 in human tumors may promote malignant progression in part by helping to stanch the death penalty associated with c-Myc activation.

摘要

Bin1基因编码一种具有肿瘤抑制和细胞死亡特性的与c-Myc相互作用的衔接蛋白。在本研究中,我们提供证据表明Bin1参与了一种机制,通过该机制c-Myc在转化的原代鸡或大鼠细胞中激活程序性细胞死亡。反义或显性抑制性Bin1基因不影响c-Myc驱动增殖或转化的能力,但它们确实降低了细胞对c-Myc诱导的凋亡的敏感性。这暗示了蛋白质-蛋白质相互作用,表明Bin1介导来自c-Myc的死亡或死亡致敏信号。我们的发现为基于与结合蛋白相互作用的Myc凋亡功能的“双信号”模型提供了直接支持。人类肿瘤中Bin1的缺失可能部分通过帮助阻止与c-Myc激活相关的死亡惩罚来促进恶性进展。

相似文献

1
Bin1 mediates apoptosis by c-Myc in transformed primary cells.Bin1通过c-Myc在转化的原代细胞中介导细胞凋亡。
Cancer Res. 2001 Apr 1;61(7):3151-6.
2
The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.与c-Myc相互作用的衔接蛋白Bin1激活非半胱天冬酶依赖性细胞死亡程序。
Oncogene. 2000 Sep 28;19(41):4669-84. doi: 10.1038/sj.onc.1203681.
3
Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.法尼基转移酶抑制剂触发的转化选择性凋亡程序需要Bin1。
Oncogene. 2003 Jun 5;22(23):3578-88. doi: 10.1038/sj.onc.1206481.
4
Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.腺病毒E1A癌蛋白通过一种依赖Rb/E2F1的机制降低Bin1表达,从而释放c-Myc活性以促进细胞增殖。
J Cell Physiol. 2008 Sep;216(3):621-31. doi: 10.1002/jcp.21437.
5
A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.基于结构的c-Myc/Bin1蛋白相互作用模型表明,Bin1的可变剪接和c-Myc磷酸化是关键的结合决定因素。
J Mol Biol. 2005 Aug 5;351(1):182-94. doi: 10.1016/j.jmb.2005.05.046.
6
Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein.新型Myc相互作用蛋白Bin1的过表达诱导神经母细胞瘤和星形细胞瘤细胞凋亡及分化
J Cell Biochem. 1999 Sep 1;74(3):313-22.
7
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.Bin1与Myc发生功能性相互作用,并通过多种机制抑制细胞增殖。
Oncogene. 1999 Jun 17;18(24):3564-73. doi: 10.1038/sj.onc.1202670.
8
BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.BIN1是一种具有肿瘤抑制因子特征的新型MYC相互作用蛋白。
Nat Genet. 1996 Sep;14(1):69-77. doi: 10.1038/ng0996-69.
9
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.Bcl-2是一个凋亡靶点,受c-Myc和E2F-1两者抑制。
Oncogene. 2001 Oct 25;20(48):6983-93. doi: 10.1038/sj.onc.1204892.
10
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.肿瘤抑制因子的消除机制:脑特异性外显子的异常剪接导致黑色素瘤中Bin1功能丧失。
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9689-94. doi: 10.1073/pnas.96.17.9689.

引用本文的文献

1
Bend it like BIN1: how a membrane-curving adaptor protein shapes cardiac physiology.像BIN1一样弯曲它:一种膜弯曲衔接蛋白如何塑造心脏生理功能。
Am J Physiol Heart Circ Physiol. 2025 Jul 1;329(1):H94-H108. doi: 10.1152/ajpheart.00198.2025. Epub 2025 May 20.
2
BIN1 inhibited tumor growth, metastasis and stemness by ALDH1/NOTCH pathway in bladder carcinoma.在膀胱癌中,BIN1通过ALDH1/NOTCH信号通路抑制肿瘤生长、转移和干性。
Hereditas. 2025 Feb 27;162(1):29. doi: 10.1186/s41065-025-00384-w.
3
Rapid flow-based synthesis of post-translationally modified peptides and proteins: a case study on MYC's transactivation domain.
基于快速流动的翻译后修饰肽和蛋白质的合成:以MYC的反式激活结构域为例
Chem Sci. 2024 May 7;15(23):8756-8765. doi: 10.1039/d4sc00481g. eCollection 2024 Jun 12.
4
BIN1 in cancer: biomarker and therapeutic target.BIN1 在癌症中的作用:生物标志物和治疗靶点。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7933-7944. doi: 10.1007/s00432-023-04673-7. Epub 2023 Mar 9.
5
BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists.BAX 作为 C-MYC 的介质使急性淋巴细胞白血病对 TLR9 激动剂敏感。
J Transl Med. 2023 Feb 10;21(1):108. doi: 10.1186/s12967-023-03969-z.
6
A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latency.全面的淋巴母细胞单细胞数据分析揭示了超级增强子在维持 EBV 潜伏期中的作用。
J Med Virol. 2023 Jan;95(1):e28362. doi: 10.1002/jmv.28362.
7
circABCB10 Promotes Malignant Progression of Gastric Cancer Cells by Preventing the Degradation of MYC.环状ABCB10通过阻止MYC的降解促进胃癌细胞的恶性进展。
J Oncol. 2021 Dec 14;2021:4625033. doi: 10.1155/2021/4625033. eCollection 2021.
8
New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.新型合成致死性使铂类耐药癌细胞对顺铂重新敏感:联合使用 PARP 和 ATM 抑制剂的原理。
Int J Mol Sci. 2021 Dec 11;22(24):13324. doi: 10.3390/ijms222413324.
9
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein.结构和生物物理洞察内在无序 Myc 癌蛋白的功能。
Cells. 2020 Apr 22;9(4):1038. doi: 10.3390/cells9041038.
10
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia.剪接因子 RBM25 控制急性髓系白血病中的 MYC 活性。
Nat Commun. 2019 Jan 11;10(1):172. doi: 10.1038/s41467-018-08076-y.